小乳头状甲状腺癌主动监测的系统评价与荟萃分析
该系统评价与荟萃分析检索Ovid-MEDLINE和EMBASE至2019年1月5日,纳入报告小乳头状甲状腺癌(PTC)主动监测(AS)随访患者的研究。主要结局为5年随访时肿瘤增大≥3 mm和淋巴结转移的年度合并比例,采用逆方差加权模型计算。结果显示5年肿瘤增大合并比例为5.3%[95%CI 4.4-6.4%],5年淋巴结转移合并比例为1.6%[95%CI 1.1-2.4%];延迟手术原因常非肿瘤增大或淋巴结转移。结论认为AS对小PTC有效,但需优化管理延迟手术的其他原因。
要点
- 小PTC主动监测5年肿瘤增大≥3 mm合并比例5.3%,淋巴结转移1.6%。
- 延迟手术原因常非肿瘤增大或淋巴结转移,需关注其他因素。
- 2015 ATA指南支持AS作为小PTC立即手术的替代方案。
核心结论
- AS是小PTC的有效管理策略,5年肿瘤增大和淋巴结转移比例低。
- 相当比例延迟手术原因非肿瘤增大或淋巴结转移,需优化管理。
研究设计与样本
- 系统评价与荟萃分析,检索Ovid-MEDLINE和EMBASE至2019年1月5日。
- 纳入报告小PTC患者AS随访的研究,由两名放射科医生独立提取数据和评估质量。
主要发现
- 5年肿瘤增大≥3 mm合并比例为5.3%[95%CI 4.4-6.4%]。
- 5年淋巴结转移合并比例为1.6%[95%CI 1.1-2.4%]。
- 许多延迟手术原因并非肿瘤增大或淋巴结转移。
关键数值与推荐
- 主要结局为5年随访肿瘤增大≥3 mm和淋巴结转移的年度合并比例,采用逆方差加权模型计算。
- 2015年美国甲状腺协会(ATA)指南将AS列为小PTC立即手术的替代方案。
临床怎么用
- 小PTC患者可考虑AS作为立即手术的替代方案。
- AS随访中需关注肿瘤增大≥3 mm和淋巴结转移,并管理其他延迟手术原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: The rapid increase in the incidence of small papillary thyroid carcinoma (PTC) appears to be caused by the detection of small thyroid cancers. Active surveillance (AS) was therefore suggested to overcome this problem. As the results were favorable with low rates of size enlargement and lymph metastasis, the 2015 American Thyroid Association Management Guidelines endorsed AS as an alternative to immediate surgery. As the clinical value of AS is a subject of ongoing active discussions and surveys, we considered a systematic review and meta-analysis to be timely and necessary. Methods: Ovid-MEDLINE and EMBASE databases were searched up to January 5, 2019, for studies reporting patients who were followed up with AS for PTC. Data extraction and methodological quality assessment were performed independently by two radiologists. The primary outcomes were to identify the annual pooled proportions of size enlargement of 3 mm or more and the detection of lymph node metastases at a 5-year follow-up period. These were calculated using an inverse-variance weighting model. An additional outcome was evaluation of the reasons for surgery during AS. Results: The pooled proportion of size enlargement occurring at 5 years was 5.3% [95% confidence interval (CI), 4.4-6.4%], and the pooled proportion of 5-year lymph node metastasis was 1.6% [CI, 1.1-2.4%]. In many subjects undergoing delayed operations, the reasons for operation were often other than those of size enlargement or lymph node metastasis. Conclusions: AS is effective for the management of small PTC, with a low proportion of size enlargement or lymph node metastasis occurring at 5 years. However, a substantial proportion of the causes of delayed surgery were other than size enlargement or lymph node metastasis, and these situations need to be optimally managed.
引用
- Cho SJ, Suh CH, Baek JH, et al. Active Surveillance for Small Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis. Thyroid. 2019. PMID: 31368412. doi:10.1089/thy.2019.0159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。